Under pathological conditions such as T2DM, myocardial ischemia, and cardiac hypertrophy, insulin signal transduction pathways are abrogated (Iliadis, Kadoglou, & Didangelos, 2011). The gene discussed is INS; the disease is type 2 diabetes mellitus.